한국어
English
日本語
中文(简体)
Nubecca Tablet 300 mg (Darolutamide)
300mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.
Darolutamide is an active ingredient used in the treatment of prostate cancer.
MFDS ingredient code M278777
Darolutamide belongs to the class of non-steroidal androgen receptor antagonists. It is primarily used to inhibit the growth of cancer cells in prostate cancer patients. This ingredient binds to the androgen receptors within cancer cells to block hormone signaling.
Darolutamide binds to the androgen receptors of prostate cancer cells, preventing the action of male hormones. As a result, signals for cancer cell growth and proliferation are blocked, slowing the progression of the cancer.
Approved uses differ by product. Check each product's information for its actual use.
Compared to other androgen receptor antagonists, darolutamide has lower permeability across the blood-brain barrier, resulting in relatively fewer central nervous system side effects. Additionally, it has a low risk of drug interactions, increasing its safety.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.